Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
Shanghai Creation Investment
ShanghaiLate Stage
INP Capital
VancouverSeed–Late Stage
5 people
Pivotal Life Sciences
Seed–Late Stage
5 people
Princeville Capital
San FranciscoSeries A–Late Stage
11 people
Horizon Technology Finance
FarmingtonGrowth–Late Stage$3M – $50M
2 people
KittyHawk Ventures
Silicon ValleySeed–Late Stage$250K – $15M
2 people
Klein & Partners AG
ZugGrowth–Late Stage$550K – $5.5M
2 people
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
1 person
Redhills Ventures LLC
Las VegasSeed–Late Stage$125K – $7M
3 people
Exit 156 Capital
CollegevilleGrowth–Late Stage
3 people
Waterpoint Lane
MiamiSeed–Late Stage
2 people
Boston Millennia Partners
BostonSeed–Late Stage$3M – $5M
7 people
Redesign Health
New YorkSeed–Late Stage
2 people
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
Majuven
SingaporeSeed–Late Stage
4 people
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
Huangpu River Capital
ShanghaiSeries C–Late Stage
Reverent Partners
SeoulSeries A–Late Stage
ALAMidas Capital Partners
Seed–Late Stage$5M – $50M
1 person
Amgen Ventures
Thousand OaksSeed–Late Stage$1M – $3M
1 person
Fluke Venture Partners
KirklandSeed–Late Stage$1M – $4M
1 person
Joseph Advisory Services
El PasoLate Stage$5M
1 person
Lotus Capital
CupertinoGrowth–Late Stage
1 person
MCI Capital S.A.
WarsawGrowth–Late Stage$27M – $108M
1 person
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.







